Follow-Up Has Improved for AMI, Heart Failure Hospitalization
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 5, 2024 -- Follow-up has improved for patients with acute myocardial infarction (AMI) and heart failure, but disparities persist in follow-up rates, according to a study published online Aug. 6 in the Annals of Internal Medicine.
Timothy S. Anderson, M.D., from the University of Pittsburgh, and colleagues describe trends and disparities in follow-up after AMI and heart failure hospitalizations in a retrospective cohort study. Data were included for 1,678,088 AMI and 4,245,665 heart failure hospitalizations.
The researchers found that from 2010 to 2019, there was an increase in the cardiology follow-up rate, from 48.3 to 61.4 percent for AMI hospitalizations and from 35.2 to 48.3 percent for heart failure hospitalizations. Follow-up rates increased for all subgroups for both conditions, but there was a worsening of disparities seen for Hispanic patients with AMI and for heart failure patients who were Asian, Black, Hispanic, Medicaid dual-eligible, and residents of counties with higher levels of social deprivation. The largest disparities by 2019 were between Black and White patients (51.9 versus 59.8 percent for AMI; 39.8 versus 48.7 percent for heart failure) and for Medicaid dual-eligible versus non-dual-eligible patients (AMI: 52.8 versus 60.4 percent; heart failure: 39.7 versus 49.4 percent). Differences between hospitals explained 7.3 and 7.7 percentage points of the variation in follow-up for AMI and heart failure, respectively.
"These findings indicate opportunities and challenges to equitably improving postdischarge care for all patients with AMI or heart failure," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Urinary Metal Levels Tied to Increased Risk for Later Heart Failure
THURSDAY, July 3, 2025 -- There are consistent associations between elevated urinary metal levels and increased heart failure risk over time across geographically diverse cohorts...
Empagliflozin Has Kidney Protective Effects in Acute Myocardial Infarction
THURSDAY, June 26, 2025 -- Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial...
Quality Improvement Initiative Ups Adherence to Medical Therapy for Heart Failure
MONDAY, June 23, 2025 -- For patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves adherence to quadruple medication therapy (QMT), defined...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.